ASSESSMENT OF PROTEIN S LEVELS IN YOUNG PATIENTS (20-45YEARS) WITH MYOCARDIAL INFARCTION REPORTING TO SHAIKH ZAYED HOSPITAL LAHORE

Main Article Content

Ahmed Latif Chaudhary
Sameen Hassan
Attia Lateef
Saleha Maqsood
Naveen Bilal
Nazish Jamil

Keywords

Protein S Deficiency, Myocardial Infarction, Young Patients

Abstract

Background: Free protein S is a physiological inhibitor of coagulation. In many studies involving, especially young subjects, decreased fibrinolysis has been observed to be related to a high risk of intravascular arterial thrombosis. This study was planned to assess young patient’s thrombotic risk potential for myocardial ischemia and infarction and preventive measures can be taken well in time in young patients with protein S deficiency.


Objective: To determine the proportion of protein S deficiency in young patients diagnosed with myocardial infarction (age 20 to 45 years).


Methodology: This descriptive observational study was carried out at the Department of Haematology, Shaikh Zayed Medical Complex, Lahore. The duration of the study was one year after approval of the synopsis. After meeting inclusion and exclusion criteria, 75 patients with myocardial infarction were enrolled. Informed consent and demographic details were taken. Venous blood samples were taken and stored in a blue top vacuum tube. If protein S levels were less than 70 U/dL, then protein S deficiency was labeled.


Results: In our study among myocardial infarction patients the protein S deficiency was noted in 21(28%) patients. In diabetic patients, protein S deficiency was noted in 18 (36.7%) patients, and in non-diabetic patients, it was noted in 3 (11.5%) patients (p-value = 0.021).Among smokers, protein S deficiency was noted in 13 (44.8%) patients and in non-smokers, it was noted in 8 (17.4%) patients (p-value = 0.010) and in patients with a family history of MI, protein S deficiency was noted in 20 (55.6%) patients and in patients without a family history of MI, it was noted in 1 (2.6%).


 Conclusion: The proportion of protein S deficiency in young patients diagnosed with myocardial infarction (age 20 to 45 years) is 28%, whereas factors like diabetes mellitus, smoking status, and family history of MI are associated with protein S deficiency in the patients.


 

Abstract 77 | pdf Downloads 8

References

1. Usman, F., Hassan, A. and Ahmad, A., 2007. Arterial ischemic stroke with protein deficiency in Pakistan. Rawal Medical Journal, 32(2), pp.205-207.
2. Lee, J.C., Lee, I.S., Choi, I.K et al. A case of acute myocardial infarction due to protein S deficiency associated with pregnancy. The Korean Journal of Medicine, 74(1), pp.170-173.
3. Meltzer, M.E., Doggen, C.J., de Groot, P.G et al. 2010. Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men. Blood, The Journal of the American Society of Hematology, 116(4), pp.529-536.
4. Larsen, T.B., Brusgaard, K. and Nybo, M., 2010. Severe arterial thrombosis in a family with type III protein S deficiency caused by a frameshift mutation in the PROS1 gene. Thrombosis Research, 126(2), pp.e159-e161.
5. Seropian, I.M., Toldo, S., Van Tassell, B.W et al. 2014. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. Journal of the American College of Cardiology, 63(16), pp.1593-1603
6. Bendary, A., Tawfik, W., Mahrous, M et al. 2017. Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen. Journal of Cardiovascular and Thoracic Research, 9(4), p.209.
7. Ali, N., Ayyub, M. and Khan, S.A., 2014. High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident. Pakistan journal of medical sciences, 30(6), p.1323.
8. Klincheva, M., Vilarova, E.A., Angjusheva, T et al. 2016. Endothelial nitric oxide synthase T-786C mutation, prothrombin gene mutation (G-20210-A) and protein S deficiency could lead to myocardial infarction in a very young male adult. Open access Macedonian journal of medical sciences, 4(1), p.142.
9. Hubert, A., Guéret, P., Leurent, G et al. 2018. Myocardial infarction and thrombophilia: Do not miss the right diagnosis!. Revista Portuguesa de Cardiologia (English Edition), 37(1), pp.89-e1.
10. Pasupathy, S., Air, T., Dreyer, R.P et al. 2016. Systematic review of patients presenting with suspected myocardial infarction and non obstructive coronary arteries. Circulation, 131(10), pp.861-870
11. Mahmoodi, B.K., Brouwer, J.L.P., ten Kate, M.K et al. 2010. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. Journal of Thrombosis and Haemostasis, 8(6), pp.1193-1200
12. Zakai, N.A., Judd, S.E., Kissela, B et al. 2018. Factor VIII, protein C and cardiovascular disease risk: the REasons for Geographic and Racial Differences in Stroke Study (REGARDS). Thrombosis and haemostasis, 118(07), pp.1305-1315.

Most read articles by the same author(s)